Avitia

Avitia improves cancer treatment via advanced molecular testing solutions, offers testing tools for use onsite, bioinformatics driven by AI.
Founded by
Investors:
PacBridge Capital Partners
Description:
Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms. By providing quicker and more precise cancer diagnostics along with tailored treatment options, this approach benefits laboratories, clinicians, and patients alike.
Key Metrics:
Total Raised
5000000
Team Size
1-10
Location
Montréal
Canada
Last Funding
February 27, 2025